Stefan Larson is a Venture Partner at Versant Ventures, and serves on the board of Northern Biologics, a Versant portfolio company. Based in the MaRS Discovery District, Stefan was the founding CEO of Blueline
Bioscience, a Versant Discovery Engine, and was the founding CEO of Northern Biologics. Stefan joined Versant after spending three years as the co-founder and CEO of Tornado Medical Systems, a revenue stage medical imaging and spectroscopy company. He previously
held the position of Associate Principal with McKinsey & Company, serving global clients in healthcare and technology. He is currently a director of the MaRS Discovery District and Ontario Bioscience Innovation Organization (OBIO), and is a recipient of the
Arbor Award for Exceptional Volunteer Service to the University of Toronto. Stefan received his B.Sc. in Biology from McGill University, and his M.Sc. in Molecular and Medical Genetics from the University of Toronto. He completed his Ph.D. in Biophysics at
Stanford University, where he helped build and launch Folding@home, the world’s most successful scientific public distributed computing platform.